Some ME/CFS patients have displayed elevated BAFF, but the gene expression of the BAFF receptor (TNFRSF13C) has been shown to be reduced in ME/CFS patients, suggesting that the elevated serum BAFF is a compensatory mechanism. The gene discussed is TNFRSF13C; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.